---  
layout: startup_page  
title: "IsomAb"  
id: "isomab.bio"  
permalink: "/isomabisomab.bio02202024/"  
website: "https://www.isomab.bio/"  
funding_round: "Seed"  
funding_amount: "£7.5M"  
investors: "Broadview Ventures, SCVC, MEIF Proof of Concept & Early Stage Fund"  
about: "IsomAb Ltd is a UK-based biotechnology company developing isoform-specific disease-modifying antibody treatments for serious and life-threatening diseases. Their initial focus is on peripheral ischemia, with a lead antibody, ISM-001, aimed at treating peripheral arterial disease, particularly in patients with metabolic syndrome and Type II diabetes."  
markets: "Biotechnology, Pharmaceuticals, Biotechnology Research"  
hq: "Nottingham, England, United Kingdom"  
founded_year: "2022"  
linkedin: "https://uk.linkedin.com/company/isomab-ltd"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/isomab?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase"  
pitchbook: ""  

date_display: "20-Feb-2024"  
date: "2024-02-20"

# SEO Optimization  
meta_title: "IsomAb - Seed Funding (£7.5M)"  
meta_description: "IsomAb, IsomAb Ltd is a UK-based biotechnology company developing isoform-specific disease-modifying antibody treatments for serious and life-threatening dise..."  
meta_keywords: "IsomAb, Biotechnology, Pharmaceuticals, Biotechnology Research, Seed funding"  
canonical_url: "https://startup.projectstartups.com/isomabisomab.bio02202024/"  
---